Lucy Kilburn
Institute of Cancer Research(GB)Cancer Research UK(GB)Institute of Cancer Research(CA)Cancer Research UK Clinical Trials Unit(GB)
Publications by Year
Research Areas
Cancer Genomics and Diagnostics, Estrogen and related hormone effects, Advanced Breast Cancer Therapies, Breast Cancer Treatment Studies, Lung Cancer Treatments and Mutations
Most-Cited Works
- → Survival and safety of exemestane versus tamoxifen after 2–3 years' tamoxifen treatment (Intergroup Exemestane Study): a randomised controlled trial(2007)908 cited
- → Carboplatin in BRCA1/2-mutated and triple-negative breast cancer BRCAness subgroups: the TNT Trial(2018)889 cited
- → Extra-pleural pneumonectomy versus no extra-pleural pneumonectomy for patients with malignant pleural mesothelioma: clinical outcomes of the Mesothelioma and Radical Surgery (MARS) randomised feasibility study(2011)708 cited
- → Plasma ESR1 Mutations and the Treatment of Estrogen Receptor–Positive Advanced Breast Cancer(2016)703 cited
- → Skeletal effects of exemestane on bone-mineral density, bone biomarkers, and fracture incidence in postmenopausal women with early breast cancer participating in the Intergroup Exemestane Study (IES): a randomised controlled study(2007)425 cited